NCT03761914 2024-11-19Galinpepimut-S in Combination With Pembrolizumab in Patients With Selected Advanced CancersSellas Life Sciences GroupPhase 1/2 Completed26 enrolled 14 charts
NCT02996474 2022-12-28Pembrolizumab and Decitabine for Refractory or Relapsed Acute Myeloid LeukemiaNational Institutes of Health Clinical Center (CC)Phase 1/2 Completed10 enrolled 12 charts